Overview

Recent News

Date	Title and Summary
Toggle Summary Aug 09, 2019	Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021 LAKE FOREST, Ill. , Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements (the “Exchange Agreements”) with a limited number of holders of Assertio’s currently outstanding 2.50%
Toggle Summary Aug 07, 2019	Assertio Therapeutics Announces Strong Second-Quarter 2019 Results -- Reports Total Company GAAP Net Sales of $57.2 million , Total Company Non-GAAP Net Sales of $59.3 million , including Commercialization Agreement Revenues of $31.0 million -- -- Drives Continued Improvement in Operating Efficiencies as the Company Executes on its Ongoing Transformation -- --
Toggle Summary Jul 17, 2019	Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019 LAKE FOREST, Ill. , July 17, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release second quarter 2019 financial results on Wednesday, August 7, 2019 , after the close of markets. Following the announcement, the Company will host a conference call

Filing date	Description	Form	Filing Group	View
Aug 15, 2018	8-K12B	8-K12B	Other	View HTML 0001104659-18-052087.pdf 0001104659-18-052087.rtf 0001104659-18-052087.xls
Mar 29, 2002	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0000912057-02-012655.pdf 0000912057-02-012655.rtf 0000912057-02-012655.xls
Mar 25, 2015	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-15-002712.pdf 0001047469-15-002712.rtf 0001047469-15-002712.xls
Apr 05, 2016	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-16-011902.pdf 0001047469-16-011902.rtf 0001047469-16-011902.xls
Mar 16, 2018	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-18-001778.pdf 0001047469-18-001778.rtf 0001047469-18-001778.xls

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com

Ernst & Young LLP
Palo Alto, CA

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com